UVI 3003 - ≥98%(HPLC), high purity , CAS No.847239-17-2, Antagonist of Retinoid X receptor-α;Antagonist of Retinoid X receptor-β

Item Number
U287111
Grouped product items
SKUSizeAvailabilityPrice Qty
U287111-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$20.90
U287111-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$86.90
U287111-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$162.90
U287111-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$652.90

RXR antagonist

Basic Description

SynonymsBS-17614 | AKOS024457539 | SCHEMBL19119381 | GTPL2816 | compound 10e [PMID: 19408900] | (2E)-3-{4-hydroxy-3-[5,5,8,8-tetramethyl-3-(pentyloxy)-5,6,7,8-tetrahydronaphthalen-2-yl]phenyl}prop-2-enoic acid | Q27089116 | UVI3003 | UVI-3003 | (E)-3-[4-hydroxy-3
Specifications & PurityMoligand™, ≥98%(HPLC)
Biochemical and Physiological MechanismsRXR antagonist; displays high RXR binding affinity. Does not affect the corepressor interaction capacity of the RARαsubunit within the context of the RAR-RXR heterodimer.
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of Retinoid X receptor-α;Antagonist of Retinoid X receptor-β
Product Description

product description:

UVI 3003 is a highly selective antagonist of retinoid X receptor (RXR), and inhibits xenopus and human RXRα with IC50 of 0.22 μM and 0.24 μM in Cos7 cells, respectively.

Associated Targets(Human)

RXRB Tclin Retinoic acid receptor RXR-beta (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
RXRA Tclin Retinoic acid receptor RXR-alpha (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
RARA Tclin Retinoic acid receptor alpha (1324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXRA Tclin Retinoid X receptor alpha (3637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXRB Tclin Retinoid X receptor beta (726 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name (E)-3-[4-hydroxy-3-(5,5,8,8-tetramethyl-3-pentoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid
INCHI InChI=1S/C28H36O4/c1-6-7-8-15-32-25-18-23-22(27(2,3)13-14-28(23,4)5)17-21(25)20-16-19(9-11-24(20)29)10-12-26(30)31/h9-12,16-18,29H,6-8,13-15H2,1-5H3,(H,30,31)/b12-10+
InChi Key APJSHECCIRQQDV-ZRDIBKRKSA-N
Canonical SMILES CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)C=CC(=O)O)O)C(CCC2(C)C)(C)C
Isomeric SMILES CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)/C=C/C(=O)O)O)C(CCC2(C)C)(C)C
PubChem CID 44566108
Molecular Weight 436.58

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

8 results found

Lot NumberCertificate TypeDateItem
B2418649Certificate of AnalysisJan 06, 2024 U287111
B2418650Certificate of AnalysisJan 06, 2024 U287111
B2418651Certificate of AnalysisJan 06, 2024 U287111
B2418673Certificate of AnalysisJan 06, 2024 U287111
B2418674Certificate of AnalysisJan 06, 2024 U287111
B2418675Certificate of AnalysisJan 06, 2024 U287111
B2418676Certificate of AnalysisJan 06, 2024 U287111
B2418677Certificate of AnalysisJan 06, 2024 U287111

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 43.66, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 43.66, Max Conc. mM: 100

Safety and Hazards(GHS)

RIDADR NONHforallmodesoftransport

Related Documents

References

1. Pérez Santín E, Germain P, Quillard F, Khanwalkar H, Rodríguez-Barrios F, Gronemeyer H, de Lera AR, Bourguet W.  (2009)  Modulating retinoid X receptor with a series of (E)-3-[4-hydroxy-3-(3-alkoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]acrylic acids and their 4-alkoxy isomers..  J Med Chem,  52  (10): (3150-8).  [PMID:19408900] [10.1021/op500134e]

Solution Calculators